Correlation Between Bank Mandiri and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank Mandiri and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Mandiri and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Mandiri Persero and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Bank Mandiri and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Mandiri with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Mandiri and Neurobo Pharmaceuticals.
Diversification Opportunities for Bank Mandiri and Neurobo Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bank and Neurobo is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bank Mandiri Persero and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Bank Mandiri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Mandiri Persero are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Bank Mandiri i.e., Bank Mandiri and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank Mandiri and Neurobo Pharmaceuticals
Assuming the 90 days horizon Bank Mandiri Persero is expected to generate 0.84 times more return on investment than Neurobo Pharmaceuticals. However, Bank Mandiri Persero is 1.2 times less risky than Neurobo Pharmaceuticals. It trades about -0.17 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 45.00 in Bank Mandiri Persero on August 27, 2024 and sell it today you would lose (6.00) from holding Bank Mandiri Persero or give up 13.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank Mandiri Persero vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Bank Mandiri Persero |
| Neurobo Pharmaceuticals |
Bank Mandiri and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank Mandiri and Neurobo Pharmaceuticals
The main advantage of trading using opposite Bank Mandiri and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Mandiri position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.The idea behind Bank Mandiri Persero and Neurobo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |